Suchergebnisse - "Taylor, Graham S"

PubPharm (88)

31

The T-cell Response to Epstein-Barr Virus-New Tricks From an Old Dog

enthalten in: Frontiers in immunology | 2019

von Long, H. | Meckiff, B. | Taylor, G.

32

Interleukin-17-positive mast cells influence outcomes from BCG for patients with CIS : Data from a comprehensive characterisation of the immune microenvironment of urothelial bladder cancer

enthalten in: PloS one | 2017

von Dowell, A. | Cobby, E. | Wen, K. | +8

CommentIn: Nat Rev Urol. 2017 Nov;14(11):639. - PMID 28994827

33

Therapeutic vaccination strategies to treat nasopharyngeal carcinoma

enthalten in: Chinese clinical oncology | 2016

von Taylor, G. | Steven, N.

34

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection : Identifying Potential Targets for Prophylactic Vaccination

enthalten in: PLoS pathogens | 2016

von Brooks, J. | Long, H. | Tierney, R. | +5

35

Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma

enthalten in: The Journal of pathology | 2015

von Yap, L. | Velapasamy, S. | Lee, H. | +11

36

T-Cell Responses to EBV

enthalten in: Current topics in microbiology and immunology | 2015

von Hislop, A. | Taylor, G.

37

The immunology of Epstein-Barr virus-induced disease

enthalten in: Annual review of immunology | 2015

von Taylor, G. | Long, H. | Brooks, J. | +2

38

The immunology of Epstein-Barr virus-induced disease

enthalten in: Annual review of immunology | 2015

von Taylor, G. | Long, H. | Brooks, J. | +2

39

Down‐regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV‐associated nasopharyngeal carcinoma

enthalten in: The journal of pathology | 2015

von Yap, L. | Velapasamy, S. | Lee, H. | +11

40

T-Cell Responses to EBV

enthalten in: Current topics in microbiology and immunology | 2015

von Hislop, A. | Taylor, G.